Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The latest results from the 2023 TEXAIS trial indicated that the use of exenatide (5 g, twice daily injections for 5 days) did not significantly reduce neurological damage within 7 days in patients with acute ischemic stroke (trial registration numbers: ACTRN12617000409370 and NCT03287076)
doi: 10.1097/MOH.0b013e328345a3d1 11 WoodfinAVoisinMBBeyrauMColomBCailleDDiapouliFMet al
Semaglutide often improves blood sugar, but during dose changes or illness, levels may rise temporarily
Community sources describe dose reduction (halving the per-injection amount) when nausea or BP-related symptoms appear
A consultation is always done first to ensure safety
